BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Business

  Viralytics Ltd And Merck & Co., Kenilworth, New Jersey, U.S.A. To Collaborate On Combination Clinical Trial Of CAVATAK And KEYTRUDA In Lung And Bladder Cancer

  November 6, 2015

   · 

  6 min read
• Job Trends

  Vistek Medical Expands, Relocates to Ohio

  November 6, 2015

   · 

  1 min read
• Business

  Misonix Incorporated Announces First Quarter Fiscal Year 2016 Financial Results

  November 6, 2015

   · 

  6 min read
• Drug Development

  Orexigen Reports Financial And Business Results For The Third Quarter Ended September 30, 2015

  November 6, 2015

   · 

  14 min read
• Drug Development

  OXiGENE Announces Positive Initial Data From Phase Ib Study Of CA4P In Combination With Pazopanib In Patients With Advanced Recurrent Ovarian Cancer

  November 6, 2015

   · 

  5 min read
• Drug Development

  Heat Biologics Reports HS-410 Phase I Bladder Cancer Trial Results At The Society For Immunotherapy Of Cancer (SITC) Annual Meeting

  November 6, 2015

   · 

  7 min read
• Drug Development

  Galena Biopharma To Present Final GALE-401 Phase II Clinical Data At The 57th American Society of Hematology Annual Meeting And Exposition

  November 6, 2015

   · 

  3 min read
• Drug Development

  Rhythm Presents Positive Data From Phase 1b Study Of Setmelanotide For The Treatment Of Genetic Obesity

  November 6, 2015

   · 

  4 min read
• Business

  Vital Therapies Announces Third Quarter 2015 Financial Results And Provides Corporate Update

  November 6, 2015

   · 

  13 min read
• Business

  Atara Biotherapeutics Announces Third Quarter 2015 Financial Results

  November 6, 2015

   · 

  1 min read